The DM–AHR model exhibits high efficacy in enhancing and reconstructing images across various cancer types, as evidenced by its PSNR, SSIM, and LPIPS metrics in Table 1 (PSNR), Table 2 (SSIM), and Table 3 (LPIPS). This evidence concerns the gene AHR and cancer.